Atezolizumab in NSCLC: Push the Positive, Bury the Negative? ...Middle East

News by : (Medscape) -
Conclusions from the first interim analysis of overall survival in the IMpower010 trial of adjuvant atezolizumab for non–small cell lung cancer has been met with some pushback. Medscape Medical News

Hence then, the article about atezolizumab in nsclc push the positive bury the negative was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Atezolizumab in NSCLC: Push the Positive, Bury the Negative? )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار